---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle announced the publication of a study validating performance of the i31-SLNB algorithm to determine sentinel lymph node biopsy positivity risk."
publishedDateTime: 2021-11-06T01:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
webUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "y9qDbb3ASjsfWCOcCMOc12bwyO527G7Gyp+fOh9M0zHtO5MTBEOWtZqVr7RAXpWW7T6a5bpXGpP8dyrY+qvC2xXy7Fr8ZewQqofHj/0NAL50xqDidUw3JHZ+gTlYhqYpZthUJkcclYLq9wXfhf/BqvJPzngjD25fuwMADdR4AdKRXLPJ5EV0Dy90g4yUZNciOqWB9rGfmt06swGeHWEUCDgIJalhOGCYHGm8Mlp8Bd1jJHWs9YqEGXzXYjkT2PN5dvZ8M5PKAzx4X+qLV77ijoJT8Baifs6oAtg9H/C96o6HbmfE3VC52w9oO3GqT6p4wSDD4q4Aw8mZynPASJlKPqRBJfe7tjC2jbeuYBo2DxQ=;4SZ3ONzDyRQDZE4YppbFWw=="
---

